ArticleFrontiers in immunology2026

Radiomics and blood biomarkers for predicting efficacy of sintilimab plus lenvatinib in advanced hepatocellular carcinoma.

Yong Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.